Literature DB >> 9158967

Using willingness to pay to value close substitutes: carrier screening for cystic fibrosis revisited.

C Donaldson1, P Shackley, M Abdalla.   

Abstract

Evidence suggests that previous uses of willingness to pay (WTP) to value close substitutes may have failed to discriminate between the alternatives being evaluated. This paper reports on the application of a new technique for measuring WTP in such contexts. The alternatives evaluated are two methods of screening for cystic fibrosis carrier status. The results suggest that the new method is more discriminating. Furthermore, the paper provides evidence, from reasons for respondents' WTP valuations and regression analyses, that the use of open-ended WTP questions is not valid. This is in line with the recommendations of a recent, influential, report on the use WTP techniques.

Entities:  

Mesh:

Year:  1997        PMID: 9158967     DOI: 10.1002/(sici)1099-1050(199703)6:2<145::aid-hec253>3.0.co;2-n

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  10 in total

1.  Acceptability of willingness to pay techniques to consumers.

Authors:  Susan J Taylor; Carol L Armour
Journal:  Health Expect       Date:  2002-12       Impact factor: 3.377

2.  Genetic testing in the European Union: does economic evaluation matter?

Authors:  Fernando Antoñanzas; R Rodríguez-Ibeas; M F Hutter; R Lorente; C Juárez; M Pinillos
Journal:  Eur J Health Econ       Date:  2011-05-20

3.  Willingness to pay for adverse drug event regulatory actions.

Authors:  Jacoline Bouvy; Just Weemers; Huub Schellekens; Marc Koopmanschap
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

4.  Eliciting patients' values by use of 'willingness to pay': letting the theory drive the method.

Authors:  C Donaldson
Journal:  Health Expect       Date:  2001-09       Impact factor: 3.377

5.  Measurement of consumer preference for treatments used to induce labour: a willingness-to-pay approach.

Authors:  Susan J. Taylor; Carol L. Armour
Journal:  Health Expect       Date:  2000-09       Impact factor: 3.377

6.  Consumer preference for dinoprostone vaginal gel using stated preference discrete choice modelling.

Authors:  Susan Taylor; Carol Armour
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

7.  Prenatal screening for cystic fibrosis carriers: an economic evaluation.

Authors:  P T Rowley; S Loader; R M Kaplan
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

8.  Measuring consumer preference for models of diabetes care delivered by pharmacists.

Authors:  Susan Taylor; Fleur Hourihan; Ines Krass; Carol Armour
Journal:  Pharm Pract (Granada)       Date:  2009-03-15

9.  Sensitivity to scale of willingness-to-pay within the context of menorrhagia.

Authors:  Sabina Sanghera; Emma Frew; Janesh Kumar Gupta; Joe Kai; Tracy Elizabeth Roberts
Journal:  Health Expect       Date:  2016-02-23       Impact factor: 3.377

10.  Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening.

Authors:  Elizabeth V Clarke; Jennifer L Schneider; Frances Lynch; Tia L Kauffman; Michael C Leo; Ana G Rosales; John F Dickerson; Elizabeth Shuster; Benjamin S Wilfond; Katrina A B Goddard
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.